QuarterHawk — Equity ResearchQuarterHawk — Equity Research

RxSight, Inc. (RXST)

Healthcare

No action
Fundamental
2
Sentiment
2
Technical
2

Do Nothing: fundamentalScore 2 and qualitativeScore 2 both fail the required ≥3 override floors (run-time shadow flag is false, so no SHADOW_FST9 paper plan is available) and the 20-day average dollar volume of ~$4.37M is below the $5M liquidity floor; the chart is a bounce-only base at 4.90 under the SMA50 5.13 and SMA200 6.19, where the pullback limit is countertrend (price < SMA50 with MACD < 0, and SMA50 < SMA200 without a reclaim) and the breakout stop is uneconomic (trigger 5.13 above the settled 5.12 high against a 3-session swingLow of 4.36 gives indicative R/R 0.83 < 1.0).

Analysis as of 2026-11-11· more than 2 trading days ago

Company overview

RxSight, Inc. specializes in light-adjustable intraocular lenses for cataract surgery, offering solutions that allow ophthalmologists to customize visual acuity post-surgery. The company markets its products primarily to eye surgeons and operates both domestically and internationally.

Fundamental

weak
Fundamental2
Speculative turnaround

RxSight's fundamentals show a cash-rich position but declining revenues and widening losses indicate high execution risk.

Cash-rich but shrinking. Third-quarter revenue fell 19% with widening losses, inventory reserves and a paused LDD production line, while $254.7 million of cash and Treasuries, zero funded debt and a valuation below book value provide substantial downside support. Weak operating fundamentals with strong liquidity and high execution risk; a speculative turnaround, not a clean fundamental story.

Sentiment

weak
Sentiment2
Negative sentiment

Market sentiment is negative, with recent analyst target cuts and no positive catalysts on the horizon.

The dominant near-term driver is the Q3 2026 print (announced), which the tape scored clearly bearish — revenue down 19% to $24.6M, LAL units down 11%, gross-margin contraction and a $16.2M net loss — followed within a day by a one-directional sell-side price-target-cut cluster (Stifel to $5, Wells Fargo lower, Piper Sandler Neutral with a cut to $8 from $10). Scoring-window sentiment is measured and negative (aggregate polarity_score ≈ -0.22 across 11 scored items with every substantive item negative) while the sentiment delta is indeterminate because the 30–90d baseline produced fewer than three unique on-topic scored items; a moderate red-flag cap applied for sharply deteriorating sentiment with no offsetting bullish catalyst, and walking the rubric from the bottom up the picture lands on the deteriorating-sentiment / no-positive-catalyst row, with no forward-dated catalyst on the calendar.

Technical

weak
Technical2
Bounce-only pattern

The stock is in a short-term bounce but lacks a confirmed trend or sufficient trading volume for a setup.

RXST closed 4.90 on 2026-11-10, holding above its short-term stack (SMA20 4.81, EMA9 4.79, EMA21 4.84, WMA9 4.77, WMA21 4.82, DEMA14 4.77, TEMA14 4.80) and above the 11-10 VWAP 4.8925, but still below the SMA50 5.13 and SMA200 6.19 with the 50-day under the 200-day — a bounce inside an intermediate/long-term downtrend, not a pullback within an uptrend. Momentum is neutral-to-repairing: RSI14 50.44, Williams %R -41.04, MACD line -0.07 / signal -0.10 / histogram +0.02 (positive and improving for five sessions but still under zero), and ADX14 17.55 confirms no established trend in either direction. ATR14 0.35 is 7.14% of price (elevated), StdDev20 0.18. The tape has printed higher lows since the 2026-11-04 capitulation low of 4.11 (4.36 → 4.59 → 4.74), which is a constructive short-term base, but it is a bounce-only structure with no confirmed trend and no resolved overhead supply. Scored 2: a valid short-term bounce attempt, not a high-quality bullish setup. The action is blocked upstream and independently of chart quality — 20-day average dollar volume of about $4.37M is below the $5M liquidity floor, and both override scores (fundamentalScore 2, qualitativeScore 2) fall below their required floor of 3.

You’re looking at 2026-11-11 — more than 2 trading days ago.

Subscribers saw this then, and see today’s score, verdict and trade plan now.

Not financial advice. For informational and educational purposes only.